Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates

Core Insights - Alignment Healthcare reported a quarterly loss of $0.05 per share, better than the Zacks Consensus Estimate of a loss of $0.12, and an improvement from a loss of $0.25 per share a year ago, resulting in an earnings surprise of 58.33% [1] - The company achieved revenues of $926.93 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 4.21%, and showing significant growth from $628.6 million in the same quarter last year [2] - Alignment Healthcare's stock has increased approximately 57.5% year-to-date, contrasting with a -5.3% decline in the S&P 500 [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.05 on revenues of $940.64 million, and for the current fiscal year, it is -$0.37 on revenues of $3.75 billion [7] - The estimate revisions trend for Alignment Healthcare is favorable, leading to a Zacks Rank 2 (Buy), indicating expected outperformance in the near future [6] Industry Context - The Medical Services industry, to which Alignment Healthcare belongs, is currently ranked in the top 28% of over 250 Zacks industries, suggesting a positive outlook for stocks within this sector [8]